Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers

By Csajka C.  

Clinical Pharmacokinetics, Vol. 41, Iss. 2, 2002-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone: A Study in Healthy Volunteers

By Yassen Ashraf  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 965-980

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic interactions of zolpidem with fluoxetine in normal healthy volunteers

By Roth-Schechter B.   Piergies A.   Johnson M.   Allard S.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 378-378

Elsevier

Access to resources Recommend Favorite

Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers

By Fleishaker J.C.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men

By Dubois E.   Derks M.   Schweitzer D.   Zwinderman A.   Dekhuijzen P.   Boxtel C.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 315-328

Springer Publishing Company

Access to resources Recommend Favorite